<?xml version="1.0" encoding="UTF-8"?>
<sec id="Sec29" class="sec">
 <div class="title" xmlns="http://www.w3.org/1999/xhtml">Vasorelaxant effect of AcEO on aorta preincubated with potassium channels blockers, TEA, 4-AP, BaCl2 and Glybenclamide</div>
 <p xmlns="http://www.w3.org/1999/xhtml">Pretreatment of aorta with potassium channels blockers; TEA (98.91% ± 3, 73; 
  <span class="italic">p</span> &gt; 0.05), 4-AP (98.05% ± 2.96; 
  <span class="italic">p</span> &gt; 0.05), BaCl
  <sub>2</sub> (103.52% ± 2.47; p &gt; 0.05) and glybenclamide (99.55% ± 2.66; 
  <span class="italic">p</span> &gt; 0.05), showed no significant changes in AcEO (0.1–100 μg/ml) induced-vasorelaxation (Fig. 
  <a rid="Fig6" ref-type="fig" href="#Fig6">6a</a>).
  <div id="Fig6" class="fig">
   <span class="label">Fig. 6</span>
   <div class="caption">
    <p>Concentration–response curves of the vasorelaxant effect of 
     <span class="italic">A. campestris</span> L. (AcEO) on (
     <span class="bold">a</span>) isolated aorta pre-contracted with Phen 1 μM, and in the presence of TEA, 4-AP, BaCl
     <sub>2</sub> and Glibenclamide, and in the presence of (
     <span class="bold">b</span>) Thapsigargin, Verapamil and Indomethacin. Values are mean ± SEM, 
     <span class="italic">n</span> = 6, and analyzed with two way ANOVA followed by Bonferroni’s post-test; *** 
     <span class="italic">p</span> &lt; 0.001 vs control
    </p>
   </div>
   <div xlink:href="12906_2017_1598_Fig6_HTML" id="MO6" class="graphic" xmlns:xlink="http://www.w3.org/1999/xlink"/>
  </div>
 </p>
</sec>
